|
시장보고서
상품코드
2067603
미국의 원격치료 모니터링 시장 규모, 점유율 및 동향 분석 보고서 : 도입 형태별, 모니터링 유형별, 최종 용도별 및 부문별 예측(2026-2033년)U.S. Remote Therapeutic Monitoring Market Size, Share & Trends Analysis Report By Deployment Mode, By Monitoring Type, By End Use, And Segment Forecasts, 2026 - 2033 |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
미국 원격 치료 모니터링 시장 개요
미국의 원격치료 모니터링 시장 규모는 2025년에 4억 3,930만 달러로 추정되며, 2033년에 16억 7,820만 달러에 달할 것으로 예측됩니다.
2026-2033년 연평균 성장률(CAGR) 18.74%로 성장할 것으로 전망됩니다. 근골격계 질환의 유병률 증가, 웨어러블 기기 및 모바일 헬스 기기의 기술 발전, 원격의료 및 텔레헬스 솔루션에 대한 수요 증가가 시장 성장을 촉진하는 요인으로 작용하고 있습니다.
또한 인공지능(AI)을 활용한 원격 치료 모니터링(RTM) 플랫폼은 고도화된 데이터 분석, 기계학습, 실시간 피드백을 활용하여 환자의 치료 경과를 보다 정확하고 효율적이며 개인 맞춤형으로 모니터링할 수 있게 해줍니다.
다음 섹션에서는 만성질환 유병률의 증가와 원격 치료 모니터링 시장을 형성하는 동향 등 주요 시장 요인에 대해 개괄적으로 설명합니다. 여기에서는 비용 절감 가능성뿐만 아니라, 시장 성장을 지원하는 보험 및 환급 정책에 대해서도 언급하고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 개요
제3장 미국의 원격치료 모니터링 시장 : 변수, 동향, 범위
제4장 미국의 원격치료 모니터링 시장 : 배포 모드별, 추정·동향 분석
제5장 미국의 원격치료 모니터링 시장 : 모니터링 유형별, 추정·동향 분석
제6장 미국의 원격치료 모니터링 시장 : 최종 용도별, 추정·동향 분석
제7장 경쟁 구도
KSA 26.06.30U.S. Remote Therapeutic Monitoring Market Summary
The U.S. remote therapeutic monitoring market size was estimated at USD 439.3 million in 2025 and is projected to reach USD 1,678.2 million by 2033, growing at a CAGR of 18.74% from 2026 to 2033. The rising prevalence of musculoskeletal disorders, technological advancements in wearables and mobile health devices, and the growing preference for telemedicine and telehealth solutions are factors driving market growth.
In addition, artificial intelligence (AI) supported remote therapeutic monitoring (RTM) platforms enable more accurate, efficient, and personalized monitoring of patients' therapeutic progress by leveraging advanced data analytics, machine learning, and real-time feedback.
The section below outlines key market factors, including the rising prevalence of chronic diseases and trends shaping the remote therapeutic monitoring market. It reflects cost reduction potential, insurance, and reimbursement policies supporting the market growth.
U.S. Remote Therapeutic Monitoring Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. remote therapeutic monitoring market report based on deployment mode, monitoring type, and end use:
- Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
- Cloud & Web based
- On-premise
- Monitoring Type Outlook (Revenue, USD Million, 2021 - 2033)
- Therapeutic Data
- Non-Physiological Data
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Healthcare Providers
- Home Healthcare
- Patients & Caregivers
- Payers
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Deployment Mode
- 1.2.2. Monitoring Type Segment
- 1.2.3. End Use Segment
- 1.3. Information analysis
- 1.3.1. Market formulation & data visualization
- 1.4. Data validation & publishing
- 1.5. Information Procurement
- 1.5.1. Primary Research
- 1.6. Information or Data Analysis
- 1.7. Market Formulation & Validation
- 1.8. Market Model
- 1.9. Total Market: CAGR Calculation
- 1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Insights Landscape
Chapter 3. U.S. Remote Therapeutic Monitoring (RTM) Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Technological Advancements in Wearables and Mobile Health Devices
- 3.2.1.2. Integration of Artificial Intelligence (AI) and Machine Learning (ML)
- 3.2.1.3. Growing preference for telemedicine and telehealth solutions
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Data security and privacy concerns
- 3.2.2.2. High initial implementation costs
- 3.2.1. Market Driver Analysis
- 3.3. Market Opportunity Analysis
- 3.4. Market Challenges Analysis
- 3.5. U.S. Remote Therapeutic Monitoring (RTM) Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
- 3.5.2.4. Environmental Landscape
- 3.5.2.5. Legal Landscape
- 3.5.2.6. Social Landscape
- 3.5.1. Industry Analysis - Porter's
- 3.6. Case Study
- 3.7. EHR Integrated RTM Solution
- 3.8. Regulatory Framework
Chapter 4. U.S. Remote Therapeutic Monitoring (RTM) Market: Deployment Mode Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. U.S. Remote Therapeutic Monitoring (RTM) Market Deployment Mode Movement Analysis
- 4.3. U.S. Remote Therapeutic Monitoring (RTM) Market Size & Trend Analysis, by Deployment Mode, 2021 to 2033 (USD Million)
- 4.4. Cloud & Web-based
- 4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.5. On-premise
- 4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. U.S. Remote Therapeutic Monitoring (RTM) Market: Monitoring Type Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. U.S. Remote Therapeutic Monitoring (RTM) Market Monitoring Type Movement Analysis
- 5.3. U.S. Remote Therapeutic Monitoring (RTM) Market Size & Trend Analysis, by Monitoring Type, 2021 to 2033 (USD Million)
- 5.4. Therapeutic Data
- 5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.5. Non-Physiological Data
- 5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. U.S. Remote Therapeutic Monitoring (RTM) Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. U.S. Remote Therapeutic Monitoring (RTM) Market End Use Movement Analysis
- 6.3. U.S. Remote Therapeutic Monitoring (RTM) Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 6.4. Healthcare Providers
- 6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.5. Home Healthcare
- 6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.6. Patients & Caregivers
- 6.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.7. Payers
- 6.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Company/Competition Categorization
- 7.2. Strategy Mapping
- 7.3. Company Market Position Analysis, 2025
- 7.4. Company Profiles/Listing
- 7.4.1. Zimmer Biomet
- 7.4.1.1. Company overview
- 7.4.1.2. Financial performance
- 7.4.1.3. Product benchmarking
- 7.4.1.4. Strategic initiatives
- 7.4.2. Medsien, Inc.
- 7.4.2.1. Company overview
- 7.4.2.2. Financial performance
- 7.4.2.3. Product benchmarking
- 7.4.2.4. Strategic initiatives
- 7.4.3. Adhere+ Corporation
- 7.4.3.1. Company overview
- 7.4.3.2. Financial performance
- 7.4.3.3. Product benchmarking
- 7.4.3.4. Strategic initiatives
- 7.4.4. Academy Medtech Ventures
- 7.4.4.1. Company overview
- 7.4.4.2. Financial performance
- 7.4.4.3. Product benchmarking
- 7.4.4.4. Strategic initiatives
- 7.4.5. CircleLink Health Inc.
- 7.4.5.1. Company overview
- 7.4.5.2. Financial performance
- 7.4.5.3. Product benchmarking
- 7.4.5.4. Strategic initiatives
- 7.4.6. Limber Health, Inc.
- 7.4.6.1. Company overview
- 7.4.6.2. Financial performance
- 7.4.6.3. Product benchmarking
- 7.4.6.4. Strategic initiatives
- 7.4.7. HealthArc
- 7.4.7.1. Company overview
- 7.4.7.2. Financial performance
- 7.4.7.3. Product benchmarking
- 7.4.7.4. Strategic initiatives
- 7.4.8. Hero Health, Inc.
- 7.4.8.1. Company overview
- 7.4.8.2. Financial performance
- 7.4.8.3. Product benchmarking
- 7.4.8.4. Strategic initiatives
- 7.4.9. Paindrainer AB
- 7.4.9.1. Company overview
- 7.4.9.2. Financial performance
- 7.4.9.3. Product benchmarking
- 7.4.9.4. Strategic initiatives
- 7.4.10. Physitrack
- 7.4.10.1. Company overview
- 7.4.10.2. Financial performance
- 7.4.10.3. Product benchmarking
- 7.4.10.4. Strategic initiatives
- 7.4.11. KangarooHealth
- 7.4.11.1. Company overview
- 7.4.11.2. Financial performance
- 7.4.11.3. Product benchmarking
- 7.4.11.4. Strategic initiatives
- 7.4.12. Spry Therapeutics Inc.
- 7.4.12.1. Company overview
- 7.4.12.2. Financial performance
- 7.4.12.3. Product benchmarking
- 7.4.12.4. Strategic initiatives
- 7.4.13. WebExercises
- 7.4.13.1. Company overview
- 7.4.13.2. Financial performance
- 7.4.13.3. Product benchmarking
- 7.4.13.4. Strategic initiatives
- 7.4.14. Blue Marble Health
- 7.4.14.1. Company overview
- 7.4.14.2. Financial performance
- 7.4.14.3. Product benchmarking
- 7.4.14.4. Strategic initiatives
- 7.4.15. MovementRX (Functional Dimensions LLC).
- 7.4.15.1. Company overview
- 7.4.15.2. Financial performance
- 7.4.15.3. Product benchmarking
- 7.4.15.4. Strategic initiatives
- 7.4.16. HealthViewX
- 7.4.16.1. Company overview
- 7.4.16.2. Financial performance
- 7.4.16.3. Product benchmarking
- 7.4.16.4. Strategic initiatives
- 7.4.17. OneStep.
- 7.4.17.1. Company overview
- 7.4.17.2. Financial performance
- 7.4.17.3. Product benchmarking
- 7.4.17.4. Strategic initiatives
- 7.4.18. IncludeHealth Inc,
- 7.4.18.1. Company overview
- 7.4.18.2. Financial performance
- 7.4.18.3. Product benchmarking
- 7.4.18.4. Strategic initiatives
- 7.4.19. Force
- 7.4.19.1. Company overview
- 7.4.19.2. Financial performance
- 7.4.19.3. Product benchmarking
- 7.4.19.4. Strategic initiatives
- 7.4.20. Propeller Health (ResMed)
- 7.4.20.1. Company overview
- 7.4.20.2. Financial performance
- 7.4.20.3. Product benchmarking
- 7.4.20.4. Strategic initiatives
- 7.4.1. Zimmer Biomet
